Condition: Ulcerative Colitis · Sponsor: Eli Lilly and Company
The main purpose of the study is to evaluate the effectiveness and safety of LY4268989 when given with mirikizumab compared to mirikizumab alone in adult participants with moderately to severely active ulcerative colitis (UC). Study participation will last approximately 118 weeks, including 104 weeks of treatment and may include up to 21 visits.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Arizona - Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| Clinnova Research - Anaheim | Anaheim, California, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| Biopharma Informatic, LLC | Los Angeles, California, United States | Recruiting |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | Recruiting |
| NeoClinical Research | Hialeah, Florida, United States | Recruiting |
| Encore Borland-Groover Clinical Research | Jacksonville, Florida, United States | Recruiting |
| Clinical Research of Osceola | Kissimmee, Florida, United States | Recruiting |
| Florida Research Institute | Lakewood Rch, Florida, United States | Recruiting |
| Alliance Medical Research | Lighthouse PT, Florida, United States | Recruiting |
| Atlantic Medical Research | Margate, Florida, United States | Recruiting |
| Digestive and Liver Center of Florida | Orlando, Florida, United States | Recruiting |
+ 135 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07186101